Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115687) titled 'A Prospective Clinical Study of TMLI as Conditioning Regimen for High-Risk Acute Leukemia' on Dec. 30, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Capital Medical University Cancer Canter, Beijing Shijitan Hospital
Condition:
High-Risk Acute Leukemia
Intervention:
Two-dimensional radiotherapy observation group:None
Helical tomographic intensity-modulated radiotherapy observation group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Two-dimensional radiotherapy observation group:60;Helical tomographic i...